BioSpace News Archive

Drug Development

Novavax Posts Positive First Look at Phase III COVID-19 Vaccine Results

The Phase III analysis of its COVID-19 vaccine candidate shows the medication demonstrated 89.3% efficacy in a large-scale study conducted in the U.K. that included the most common strain of the virus, as well as variants.

January 29, 2021
·
4 min read
·
Alex Keown
Novel Therapeutic May Offer Complete Response for Immuno-Inflammatory Diseases

There are severely limited therapeutic options for immuno-inflammatory diseases such as acute graft vs. host disease (aGVHD), lupus and asthma.

January 29, 2021
·
5 min read
·
Gail Dutton
Drug Development

Vertex Moves Full Steam Ahead on Type 1 Diabetes Drug Trial With FDA’s OK

The U.S. Food and Drug Administration (FDA) has cleared an Investigational New Drug application that will allow Boston-based Vertex Pharmaceuticals to proceed with a clinical trial of its investigational stem cell-derived, fully differentiated pancreatic islet cell treatment for type 1 diabetes (T1D).

January 29, 2021
·
3 min read
·
Brandon May
Drug Development

Johnson & Johnson COVID-19 Vaccine’s 66% Efficacy Rate Not the Entire Story

Overall, against moderate-severe COVID-19 infection, the vaccine was 72% effective 28 days after vaccination in the U.S., 66% in hard-hit Latin America, and bottomed out at 57% in South Africa.

January 29, 2021
·
3 min read
·
Heather McKenzie
Policy

FDA Delays Decision for Biogen’s Alzheimer’s Drug Until June

The decision by the FDA on the drug application was expected on March 7, but is now delayed until June 7, 2021.

January 29, 2021
·
4 min read
·
Mark Terry
Business

Pharma Industry Comes Together to Support Manufacture of COVID-19 Vaccines

The pharmaceutical industry continues to demonstrate its willingness to team up in the ongoing combat against the global COVID-19 pandemic.

January 29, 2021
·
2 min read
·
Alex Keown
FDA

FDA Action Alert: Adamas, Mallinckrodt and Merck

February is kicking off with a number of PDUFA dates for the U.S. FDA as well as a cancer advisory committee meeting. Here’s a look.

January 29, 2021
·
3 min read
·
Mark Terry
Job Trends

Life Sciences Companies Growing in a Pandemic-Induced Depression

While companies around the globe reduce staff amidst economic upheaval, there’s at least one industry on the rise - life sciences. Here’s who’s breaking ground on expansion projects.

January 29, 2021
·
4 min read
·
Kate Goodwin
Business

Illumina Partners with Sequoia Capital for its 3rd Life Science Incubator, This One in China

Illumina, the world’s leading DNA sequencing and array-based technologies company, is partnering with Sequoia Capital China, an investment firm, to launch a life sciences incubator in China. It is dubbed the Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina.

January 29, 2021
·
3 min read
·
Mark Terry
Drug Development

Elevian Targets Aging to Solve Humanity’s Toughest Diseases

Elevian believes that this single protein, a key player in the circulatory system, could be a game-changer in regenerative medicine.

January 29, 2021
·
6 min read
·
Heather McKenzie